Cargando…
A 2-Pyridone-Amide Inhibitor Targets the Glucose Metabolism Pathway of Chlamydia trachomatis
In a screen for compounds that inhibit infectivity of the obligate intracellular pathogen Chlamydia trachomatis, we identified the 2-pyridone amide KSK120. A fluorescent KSK120 analogue was synthesized and observed to be associated with the C. trachomatis surface, suggesting that its target is bacte...
Autores principales: | Engström, Patrik, Krishnan, K. Syam, Ngyuen, Bidong D., Chorell, Erik, Normark, Johan, Silver, Jim, Bastidas, Robert J., Welch, Matthew D., Hultgren, Scott J., Wolf-Watz, Hans, Valdivia, Raphael H., Almqvist, Fredrik, Bergström, Sven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Microbiology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281921/ https://www.ncbi.nlm.nih.gov/pubmed/25550323 http://dx.doi.org/10.1128/mBio.02304-14 |
Ejemplares similares
-
Methyl sulfonamide substituents improve the pharmacokinetic properties of bicyclic 2-pyridone based Chlamydia trachomatis inhibitors
por: Kulén, Martina, et al.
Publicado: (2019) -
Chlamydia trachomatis’ struggle to keep its host
alive
por: Sixt, Barbara S., et al.
Publicado: (2017) -
Ptr/CTL0175 Is Required for the Efficient Recovery of Chlamydia trachomatis From Stress Induced by Gamma-Interferon
por: Panzetta, María E., et al.
Publicado: (2019) -
Detección de infección por Chlamydia trachomatis en mujeres sexualmente activas en Venezuela
por: Joya, Milagros, et al.
Publicado: (2022) -
Chlamydia Trachomatis Tonsillopharyngitis
por: Öztürk, Özmen, et al.
Publicado: (2012)